Haroun Gajraj: Upto 30% of Patients Develop Brown Marks After Microsclerotherapy
Haroun Gajraj, Phlebologist and Board Member of the British Association of Sclerotherapists, shared a post on LinkedIn:
“Upto 30% of Patients Develop Brown Marks After Microsclerotherapy
That’s not a rare complication.
That’s one in three.
In fact if it occurs in 30% is it really a complication?
Is it a side effect?
Is it an expectation?
For a procedure patients choose to improve their appearance, post-sclerotherapy hyperpigmentation can be more distressing than the original spider veins – and more damaging to your patient relationship.
But can it be mitigated by the consultation process?
The question isn’t whether it happens in your practice.
It’s whether you know WHY it happens – and What to do about it.”
Other posts featuring Haroun Gajraj on Hemostasis Today.
-
Jul 9, 2026, 14:49Celebrating a Century of von Willebrand Disease Research and Care – Seminars in Thrombosis and Hemostasis
-
Jul 9, 2026, 14:38Valance Washington: International Hemostasis Community Prepares for GRC 2026
-
Jul 9, 2026, 14:27Dima Shulkin: Next-Generation AI Models Improve Early Sepsis Recognition
-
Jul 9, 2026, 14:12Omar Hajji: Seasonal Determinants of Mortality in Sepsis and Cardiogenic Shock
-
Jul 9, 2026, 13:54Hussein Yassine: Why Omega-3s May Fall Short in Preventing Alzheimer’s Disease
-
Jul 9, 2026, 13:16Olivier Mathieu: Innovating the Future of Hemostasis at ISTH 2026
-
Jul 9, 2026, 12:41Thomas Palmer-Dench: Hexokinase Controls Platelet Activation and Hemostasis
-
Jul 9, 2026, 12:19Paschalis Evangelidis: Join Our Special Issue on Thrombosis and Vascular Disorders
-
Jul 9, 2026, 12:16Fernanda Betti Solano: Could Iron Deficiency Be Affecting Your Sleep?